In 2014, Jia W et al. 21 reported that BCL6B is abundantly expressed in normal liver tissue but downregulated in six of nine hepatocellular carcinoma (HCC) cell lines, again correlating with promoter hypermethylation. This evidence concerns the gene BCL6B and hepatocellular carcinoma.